BorgWarner appoints Vicki L. Sato to Board of Directors
AUBURN HILLS, Mich., Feb. 12, 2014
AUBURN HILLS, Mich., Feb. 12, 2014 /PRNewswire/ --BorgWarner announced today
that Vicki L. Sato has been named to its board of directors. Dr. Sato has
served as Professor of Management Practice at Harvard Business School and
Professor of the Practice in the Department of Molecular and Cellular Biology
of Harvard University since 2006. Prior to that, she was President of Vertex
Pharmaceuticals from 2000 to 2005.
"Dr. Sato is an accomplished executive and scientist with over 25 years of
experience in leadership and innovation," said Alexis P. Michas, Non-Executive
Chairman, BorgWarner. "Effective innovation has been a core value at
BorgWarner and we are confident Dr. Sato will make a significant contribution
to the Board."
Dr. Sato is currently a director of publicly held Bristol-Myers Squibb
Company, Perkin Elmer Corporation and Galapagos NV.
BorgWarner Inc. (NYSE: BWA) is a product leader in highly engineered
components and systems for powertrains around the world. Operating
manufacturing and technical facilities in 56 locations in 19 countries, the
company delivers innovative powertrain solutions to improve fuel economy,
reduce emissions and enhance performance. For more information, please visit
SOURCE BorgWarner Inc.
Contact: Ken Lamb, 248.754.0884
Press spacebar to pause and continue. Press esc to stop.